DK1307241T3 - Fotodynamisk behandling og UV-B-bestråling af en thrombozytsuspension - Google Patents

Fotodynamisk behandling og UV-B-bestråling af en thrombozytsuspension

Info

Publication number
DK1307241T3
DK1307241T3 DK01957701T DK01957701T DK1307241T3 DK 1307241 T3 DK1307241 T3 DK 1307241T3 DK 01957701 T DK01957701 T DK 01957701T DK 01957701 T DK01957701 T DK 01957701T DK 1307241 T3 DK1307241 T3 DK 1307241T3
Authority
DK
Denmark
Prior art keywords
irradiation
photodynamic treatment
thrombocyte suspension
thrombocyte
suspension
Prior art date
Application number
DK01957701T
Other languages
Danish (da)
English (en)
Inventor
Anette Redecker-Klein
Harald Mohr
Original Assignee
Blutspendedienst Dt Rote Kreuz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blutspendedienst Dt Rote Kreuz filed Critical Blutspendedienst Dt Rote Kreuz
Application granted granted Critical
Publication of DK1307241T3 publication Critical patent/DK1307241T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/124—Disinfecting agents, e.g. antimicrobials
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/16—Physical preservation processes
    • A01N1/168—Physical preservation processes using electromagnetic fields or radiation; using acoustic waves or corpuscular radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Hematology (AREA)
  • Environmental Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Materials For Medical Uses (AREA)
  • Radiation-Therapy Devices (AREA)
DK01957701T 2000-07-04 2001-07-04 Fotodynamisk behandling og UV-B-bestråling af en thrombozytsuspension DK1307241T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10031851A DE10031851B4 (de) 2000-07-04 2000-07-04 Photodynamische Behandlung und UV-B-Bestrahlung einer Thrombozyten-Suspension
PCT/DE2001/002410 WO2002002152A1 (de) 2000-07-04 2001-07-04 Photodynamische behandlung und uv-b- bestrahlung einer thrombozyten-suspension

Publications (1)

Publication Number Publication Date
DK1307241T3 true DK1307241T3 (da) 2005-08-08

Family

ID=7647321

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01957701T DK1307241T3 (da) 2000-07-04 2001-07-04 Fotodynamisk behandling og UV-B-bestråling af en thrombozytsuspension

Country Status (19)

Country Link
US (1) US20040072139A1 (cs)
EP (1) EP1307241B1 (cs)
CN (1) CN1264577C (cs)
AT (1) ATE296118T1 (cs)
AU (2) AU2001279556B2 (cs)
BR (1) BR0111958A (cs)
CA (1) CA2415063C (cs)
CZ (1) CZ300018B6 (cs)
DE (2) DE10031851B4 (cs)
DK (1) DK1307241T3 (cs)
EA (1) EA004246B1 (cs)
ES (1) ES2241850T3 (cs)
HU (1) HU226418B1 (cs)
MX (1) MXPA02012663A (cs)
PL (1) PL363076A1 (cs)
PT (1) PT1307241E (cs)
SK (1) SK1002003A3 (cs)
WO (1) WO2002002152A1 (cs)
ZA (1) ZA200300257B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US6843961B2 (en) * 2000-06-15 2005-01-18 Gambro, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
WO2003063915A1 (en) * 2002-02-01 2003-08-07 Gambro, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
EP1496114A1 (de) * 2003-07-07 2005-01-12 Margraf, Stefan, Dr.med. Verfahren zur Inaktivierung von Mikroorganismen
DE102010017687A1 (de) * 2010-07-01 2012-01-05 Claas Selbstfahrende Erntemaschinen Gmbh Verfahren zur Einstellung zumindest eines Arbeitsorganes einer selbstfahrenden Erntemaschine
CN105561359B (zh) * 2016-02-02 2019-04-05 汪相伯 一种基于核黄素光化学法的血液制品处理系统

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3930510A1 (de) * 1989-09-13 1991-03-21 Blutspendedienst Dt Rote Kreuz Verfahren zur inaktivierung von viren in blut und blutprodukten
US6348309B1 (en) * 1989-09-13 2002-02-19 Blutspendedienst Der Landesverbaende Des Deutschen Roten Kreuzes Niedersachsen, Oldenburg Und Bremen G.G.M.B.H. Process for inactivating viruses in blood and blood products
US5545516A (en) * 1990-05-01 1996-08-13 The American National Red Cross Inactivation of extracellular enveloped viruses in blood and blood components by phenthiazin-5-ium dyes plus light
US6077659A (en) * 1990-05-15 2000-06-20 New York Blood Center, Inc. Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light
AU691672B2 (en) * 1994-09-22 1998-05-21 Baxter International Inc. Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers
EP1842561A1 (fr) * 1995-07-14 2007-10-10 CAF - DCF cvba - scrl Procédé et installation d'inactivation UV de virus dans des produits sanguins
US20010053547A1 (en) * 1995-12-04 2001-12-20 Slichter Sherrill J. Method for preparing a platelet composition
EP0973383A4 (en) * 1997-01-21 2001-08-22 American Nat Red Cross INTRACELLULAR AND EXTRACELLULAR DECONTAMINATION OF WHOLE BLOOD AND BLOOD COMPONENTS WITH AMPHIPHILEN PHENOTHIAZINE-5-IUM DYES AND LIGHT
US6258577B1 (en) * 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers

Also Published As

Publication number Publication date
EP1307241B1 (de) 2005-05-25
US20040072139A1 (en) 2004-04-15
PL363076A1 (pl) 2004-11-15
AU7955601A (en) 2002-01-14
EA200300111A1 (ru) 2003-06-26
CA2415063C (en) 2006-10-03
ES2241850T3 (es) 2005-11-01
CA2415063A1 (en) 2002-12-30
HUP0301717A3 (en) 2005-12-28
DE10031851B4 (de) 2005-10-13
DE50106329D1 (de) 2005-06-30
WO2002002152A1 (de) 2002-01-10
PT1307241E (pt) 2005-08-31
ZA200300257B (en) 2003-11-04
SK1002003A3 (en) 2003-06-03
HUP0301717A2 (hu) 2003-08-28
BR0111958A (pt) 2003-07-01
CN1440297A (zh) 2003-09-03
CN1264577C (zh) 2006-07-19
EP1307241A1 (de) 2003-05-07
ATE296118T1 (de) 2005-06-15
AU2001279556B2 (en) 2006-07-06
MXPA02012663A (es) 2004-07-30
CZ300018B6 (cs) 2009-01-14
DE10031851A1 (de) 2002-01-24
EA004246B1 (ru) 2004-02-26
CZ200315A3 (cs) 2003-05-14
HU226418B1 (en) 2008-12-29

Similar Documents

Publication Publication Date Title
CO4970820A1 (es) Sal de bisulfato del inhibidor de la vih-proteasa
ATE295355T1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
CY1105266T1 (el) Αποστειρωση γλυκοκορτικοστepοειδων εναιωρηματων
DK0758904T3 (da) Fremgangsmåder og sammensætninger til behandling af glomerulonephritis
DK1212422T3 (da) Humane CTLA-4-antistoffer og anvendelserne deraf
CY1108655T1 (el) ΘΕΙΟΖΟΛΙΔΙΝ-4-ΟΝΕΣ ΓΙΑ ΤΗΝ ΑΝΑΣΤΟΛΗ ΠΡΩΤΕΪΝΩΝ hYAK3
CY1107439T1 (el) Μεθοδοι προληψης και θεραπειας μολυνσης απο ιο του γενους flavivirus σε ζωα
ATE430742T1 (de) Pyrimidinamine als angiogenesemodulatoren
DK0431129T3 (da) Fremgangsmåder til inaktivering af virus i viruskontaminerede farmaceutiske præparater
DE60234760D1 (de) Phenylindole zur behandlung von hiv
ATE402713T1 (de) Genetisch manipulierte herpesviren zur behandlung von tumoren
DE69926565D1 (de) Durch freie Radikale polymerisierende, latente UV-Absorber enthaltende okulare Vorrichtungen
DE59406150D1 (de) Tiefenfilter zur abtötung von mikroorganismen und inaktivierung von viren und dessen anwendung
EP1052988A4 (en) METHODS AND COMPILATIONS FOR INACTIVATING VIRUSES
PL363076A1 (pl) Fotodynamiczne traktowanie i napromieniowanie promieniami UV-B zawiesiny trombocytów
DE60333205D1 (de) Histaminika zur behandlung von allergischer rhinitis
YU33795A (sh) Smese koncentrata suspenzija insekti-cidnih i akaricidnih sredstava arilpirola
DK0380359T3 (da) Biocide midler og behandlingsfremgangsmåder
DK0768886T3 (da) Endothelforingseffekter og behandling af vasospastiske lidelser
DE60200302D1 (de) Laseraugenbehandlungseinrichtung
ATE517617T1 (de) Behandlung von parkinson erkrankung mit kape
IT1278056B1 (it) Derivati della s-triazina, loro preparazione e loro impiego come assorbenti uv.
DE60138371D1 (de) PROSTAGLANDINE zur Behandlung von Lichtstrahlung erzeugten Augenerkrankungen wie Photoretinitis
ATE308345T1 (de) Verfahren zur inaktivierung von bakterien und leukozyten in thrombozyten-suspensionen
DE60221104D1 (de) Substituierte diarylharnstoffe als stimulatoren der fas-vermittelten apoptose